Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Tonya M BlissR M Sapolsky

Abstract

Increasing evidence suggests that glutamate activates the generation of lactate from glucose in astrocytes; this lactate is shuttled to neurons that use it as a preferential energy source. We explore this multicellular "lactate shuttle" with a novel dual-cell, dual-gene therapy approach and determine the neuroprotective potential of enhancing this shuttle. Viral vector-driven overexpression of a glucose transporter in glia enhanced glucose uptake, lactate efflux, and the glial capacity to protect neurons from excitotoxicity. In parallel, overexpression of a lactate transporter in neurons enhanced lactate uptake and neuronal resistance to excitotoxicity. Finally, overexpression of both transgenes in the respective cell types provided more protection than either therapy alone, demonstrating that a dual-cell, dual-gene therapy approach gives greater neuroprotection than the conventional single-cell, single-gene strategy.

Citations

Apr 6, 2005·Trends in Pharmacological Sciences·Keith T Akama, Bruce S McEwen
Apr 29, 2014·Neuropharmacology·Marta RuizMinerva Giménez Y Ribotta
Apr 17, 2010·ASN Neuro·Gautam K GandhiGerald A Dienel
Jun 15, 2005·Journal of Neurochemistry·Karin Pierre, Luc Pellerin
Oct 13, 2006·Journal of Neurochemistry·Carole EscartinGilles Bonvento
Feb 28, 2006·Neurochemistry International·Leif Hertz
May 23, 2015·Neuron·Pierre J Magistretti, Igor Allaman
Oct 21, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Egle Cekanaviciute, Marion S Buckwalter
Mar 21, 2017·Glia·Qian WangTian-Ming Gao
Oct 27, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Luc Pellerin, Pierre J Magistretti
Oct 2, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Camille Robinet, Luc Pellerin
Jul 31, 2007·Glia·Luc PellerinPierre J Magistretti
Apr 3, 2008·Glia·Mathilde GavilletPierre J Magistretti
Apr 23, 2005·Glia·Gerald A Dienel, Leif Hertz
Feb 23, 2019·The European Journal of Neuroscience·Mariam CharkvianiDavid Lominadze
Nov 5, 2005·The Journal of Biological Chemistry·Beatriz PardoJorgina Satrústegui
Feb 18, 2017·Frontiers in Neuroscience·Shayne Mason
May 1, 2021·International Journal of Molecular Sciences·David PamiesMarie-Gabrielle Zurich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

© 2022 Meta ULC. All rights reserved